I disagree. EPS up 18%, Class Portfolio building momentum and the signal that they are well positioned to pursue acquisitions. IMO, this growth story is set to continue. Rokewa
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game